MRFRの分析によると、短時間作用型インスリン市場規模は2022年に15.67 (10億ドル)と推定されました。この市場は2023年の16.24 (10億ドル)から2032年までに22.3 (10億ドル) に成長し、予測期間中 (2024-2032) のCAGRは約3.59%になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. SHORT ACTING INSULIN MARKET, BY INSULIN FORMULATION (USD BILLION)
6.1. Regular Insulin
6.2. Rapid-Acting Insulin
7. SHORT ACTING INSULIN MARKET, BY DOSAGE FORM (USD BILLION)
7.1. Vials
7.2. Pre-filled Pens
7.3. Cartridges
8. SHORT ACTING INSULIN MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
8.1. Subcutaneous
8.2. Intravenous
9. SHORT ACTING INSULIN MARKET, BY PATIENT TYPE (USD BILLION)
9.1. Type 1 Diabetes
9.2. Type 2 Diabetes
10. SHORT ACTING INSULIN MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
10.1. Pharmacies
10.2. Hospital Pharmacies
10.3. Online Pharmacies
11. SHORT ACTING INSULIN MARKET, BY REGIONAL (USD BILLION)
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. UK
11.2.3. France
11.2.4. Russia
11.2.5. Italy
11.2.6. Spain
11.2.7. Rest of Europe
11.3. APAC
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Malaysia
11.3.6. Thailand
11.3.7. Indonesia
11.3.8. Rest of APAC
11.4. South America
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of South America
11.5. MEA
11.5.1. GCC Countries
11.5.2. South Africa
11.5.3. Rest of MEA
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market share Analysis
12.4. Major Growth Strategy in the Short Acting Insulin Market
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Short Acting Insulin Market
12.7. Key developments and growth strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales and Operating Income
12.8.2. Major Players R&D Expenditure. 2023
13. COMPANY PROFILES
13.1. Sumitomo Dainippon Pharma
13.1.1. Financial Overview
13.1.2. Products Offered
13.1.3. Key Developments
13.1.4. SWOT Analysis
13.1.5. Key Strategies
13.2. Eli Lilly
13.2.1. Financial Overview
13.2.2. Products Offered
13.2.3. Key Developments
13.2.4. SWOT Analysis
13.2.5. Key Strategies
13.3. Sanofi
13.3.1. Financial Overview
13.3.2. Products Offered
13.3.3. Key Developments
13.3.4. SWOT Analysis
13.3.5. Key Strategies
13.4. Roche
13.4.1. Financial Overview
13.4.2. Products Offered
13.4.3. Key Developments
13.4.4. SWOT Analysis
13.4.5. Key Strategies
13.5. AstraZeneca
13.5.1. Financial Overview
13.5.2. Products Offered
13.5.3. Key Developments
13.5.4. SWOT Analysis
13.5.5. Key Strategies
13.6. Teva Pharmaceuticals
13.6.1. Financial Overview
13.6.2. Products Offered
13.6.3. Key Developments
13.6.4. SWOT Analysis
13.6.5. Key Strategies
13.7. Daiichi Sankyo
13.7.1. Financial Overview
13.7.2. Products Offered
13.7.3. Key Developments
13.7.4. SWOT Analysis
13.7.5. Key Strategies
13.8. Bayer
13.8.1. Financial Overview
13.8.2. Products Offered
13.8.3. Key Developments
13.8.4. SWOT Analysis
13.8.5. Key Strategies
13.9. Pfizer
13.9.1. Financial Overview
13.9.2. Products Offered
13.9.3. Key Developments
13.9.4. SWOT Analysis
13.9.5. Key Strategies
13.10. Baxter International
13.10.1. Financial Overview
13.10.2. Products Offered
13.10.3. Key Developments
13.10.4. SWOT Analysis
13.10.5. Key Strategies
13.11. BristolMyers Squibb
13.11.1. Financial Overview
13.11.2. Products Offered
13.11.3. Key Developments
13.11.4. SWOT Analysis
13.11.5. Key Strategies
13.12. Novartis
13.12.1. Financial Overview
13.12.2. Products Offered
13.12.3. Key Developments
13.12.4. SWOT Analysis
13.12.5. Key Strategies
13.13. Boehringer Ingelheim
13.13.1. Financial Overview
13.13.2. Products Offered
13.13.3. Key Developments
13.13.4. SWOT Analysis
13.13.5. Key Strategies
13.14. Mylan
13.14.1. Financial Overview
13.14.2. Products Offered
13.14.3. Key Developments
13.14.4. SWOT Analysis
13.14.5. Key Strategies
13.15. Novo Nordisk
13.15.1. Financial Overview
13.15.2. Products Offered
13.15.3. Key Developments
13.15.4. SWOT Analysis
13.15.5. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 7. NORTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 8. US SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 9. US SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 10. US SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 11. US SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 12. US SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 13. US SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 17. CANADA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. CANADA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 19. CANADA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 22. EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 23. EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 24. EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 25. EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 27. GERMANY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 28. GERMANY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 29. GERMANY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 30. GERMANY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 31. GERMANY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. UK SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 33. UK SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 34. UK SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 35. UK SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 36. UK SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 37. UK SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 38. FRANCE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 39. FRANCE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 40. FRANCE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 41. FRANCE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 42. FRANCE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 43. FRANCE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 44. RUSSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 45. RUSSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 46. RUSSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 47. RUSSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. RUSSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 49. RUSSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 50. ITALY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 51. ITALY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 52. ITALY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 53. ITALY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 54. ITALY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 55. ITALY SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 56. SPAIN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 57. SPAIN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 58. SPAIN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 59. SPAIN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 60. SPAIN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 61. SPAIN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. REST OF EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 63. REST OF EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 64. REST OF EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 65. REST OF EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 66. REST OF EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 67. REST OF EUROPE SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 68. APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 69. APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 70. APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 71. APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 72. APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 73. APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 74. CHINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 75. CHINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 76. CHINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 77. CHINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. CHINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 79. CHINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 80. INDIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 81. INDIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 82. INDIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 83. INDIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 84. INDIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 85. INDIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 86. JAPAN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 87. JAPAN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 88. JAPAN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 89. JAPAN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 90. JAPAN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 91. JAPAN SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. SOUTH KOREA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 93. SOUTH KOREA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 94. SOUTH KOREA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 95. SOUTH KOREA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 96. SOUTH KOREA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 97. SOUTH KOREA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 98. MALAYSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 99. MALAYSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 100. MALAYSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 101. MALAYSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 102. MALAYSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 103. MALAYSIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 104. THAILAND SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 105. THAILAND SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 106. THAILAND SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 107. THAILAND SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. THAILAND SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 109. THAILAND SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 110. INDONESIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 111. INDONESIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 112. INDONESIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 113. INDONESIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 114. INDONESIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 115. INDONESIA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 116. REST OF APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 117. REST OF APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 118. REST OF APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 119. REST OF APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 120. REST OF APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 121. REST OF APAC SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 123. SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 124. SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 125. SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 126. SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 127. SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 128. BRAZIL SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 129. BRAZIL SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 130. BRAZIL SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 131. BRAZIL SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 132. BRAZIL SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 133. BRAZIL SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 134. MEXICO SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 135. MEXICO SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 136. MEXICO SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 137. MEXICO SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. MEXICO SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 139. MEXICO SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 140. ARGENTINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 141. ARGENTINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 142. ARGENTINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 143. ARGENTINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 144. ARGENTINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 145. ARGENTINA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 147. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 148. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 149. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 150. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 151. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 152. MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 153. MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 154. MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 155. MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 156. MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 157. MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 158. GCC COUNTRIES SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 159. GCC COUNTRIES SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 160. GCC COUNTRIES SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 161. GCC COUNTRIES SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 162. GCC COUNTRIES SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 163. GCC COUNTRIES SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 164. SOUTH AFRICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 165. SOUTH AFRICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 166. SOUTH AFRICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 167. SOUTH AFRICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 168. SOUTH AFRICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 169. SOUTH AFRICA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 170. REST OF MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY INSULIN FORMULATION, 2019-2032 (USD BILLIONS)
TABLE 171. REST OF MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DOSAGE FORM, 2019-2032 (USD BILLIONS)
TABLE 172. REST OF MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 173. REST OF MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY PATIENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 174. REST OF MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 175. REST OF MEA SHORT ACTING INSULIN MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 176. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 177. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS
FIGURE 3. US SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 4. US SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 5. US SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 6. US SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 7. US SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 8. US SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 9. CANADA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 10. CANADA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 11. CANADA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 12. CANADA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 13. CANADA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 14. CANADA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 15. EUROPE SHORT ACTING INSULIN MARKET ANALYSIS
FIGURE 16. GERMANY SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 17. GERMANY SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 18. GERMANY SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 19. GERMANY SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 20. GERMANY SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 21. GERMANY SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 22. UK SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 23. UK SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 24. UK SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 25. UK SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 26. UK SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 27. UK SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 28. FRANCE SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 29. FRANCE SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 30. FRANCE SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 31. FRANCE SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 32. FRANCE SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 33. FRANCE SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 34. RUSSIA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 35. RUSSIA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 36. RUSSIA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 37. RUSSIA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 38. RUSSIA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 39. RUSSIA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 40. ITALY SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 41. ITALY SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 42. ITALY SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 43. ITALY SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 44. ITALY SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 45. ITALY SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 46. SPAIN SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 47. SPAIN SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 48. SPAIN SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 49. SPAIN SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 50. SPAIN SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 51. SPAIN SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 52. REST OF EUROPE SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 53. REST OF EUROPE SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 54. REST OF EUROPE SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 55. REST OF EUROPE SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 56. REST OF EUROPE SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 57. REST OF EUROPE SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 58. APAC SHORT ACTING INSULIN MARKET ANALYSIS
FIGURE 59. CHINA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 60. CHINA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 61. CHINA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 62. CHINA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 63. CHINA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 64. CHINA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 65. INDIA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 66. INDIA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 67. INDIA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 68. INDIA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 69. INDIA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 70. INDIA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 71. JAPAN SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 72. JAPAN SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 73. JAPAN SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 74. JAPAN SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 75. JAPAN SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 76. JAPAN SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 77. SOUTH KOREA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 78. SOUTH KOREA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 79. SOUTH KOREA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 80. SOUTH KOREA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 81. SOUTH KOREA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 82. SOUTH KOREA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 83. MALAYSIA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 84. MALAYSIA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 85. MALAYSIA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 86. MALAYSIA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 87. MALAYSIA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 88. MALAYSIA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 89. THAILAND SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 90. THAILAND SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 91. THAILAND SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 92. THAILAND SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 93. THAILAND SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 94. THAILAND SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 95. INDONESIA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 96. INDONESIA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 97. INDONESIA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 98. INDONESIA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 99. INDONESIA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 100. INDONESIA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 101. REST OF APAC SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 102. REST OF APAC SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 103. REST OF APAC SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 104. REST OF APAC SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 105. REST OF APAC SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 106. REST OF APAC SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 107. SOUTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS
FIGURE 108. BRAZIL SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 109. BRAZIL SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 110. BRAZIL SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 111. BRAZIL SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 112. BRAZIL SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 113. BRAZIL SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 114. MEXICO SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 115. MEXICO SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 116. MEXICO SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 117. MEXICO SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 118. MEXICO SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 119. MEXICO SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 120. ARGENTINA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 121. ARGENTINA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 122. ARGENTINA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 123. ARGENTINA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 124. ARGENTINA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 125. ARGENTINA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 126. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 127. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 128. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 129. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 130. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 131. REST OF SOUTH AMERICA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 132. MEA SHORT ACTING INSULIN MARKET ANALYSIS
FIGURE 133. GCC COUNTRIES SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 134. GCC COUNTRIES SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 135. GCC COUNTRIES SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 136. GCC COUNTRIES SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 137. GCC COUNTRIES SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 138. GCC COUNTRIES SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 139. SOUTH AFRICA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 140. SOUTH AFRICA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 141. SOUTH AFRICA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 142. SOUTH AFRICA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 143. SOUTH AFRICA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 144. SOUTH AFRICA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 145. REST OF MEA SHORT ACTING INSULIN MARKET ANALYSIS BY INSULIN FORMULATION
FIGURE 146. REST OF MEA SHORT ACTING INSULIN MARKET ANALYSIS BY DOSAGE FORM
FIGURE 147. REST OF MEA SHORT ACTING INSULIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 148. REST OF MEA SHORT ACTING INSULIN MARKET ANALYSIS BY PATIENT TYPE
FIGURE 149. REST OF MEA SHORT ACTING INSULIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 150. REST OF MEA SHORT ACTING INSULIN MARKET ANALYSIS BY REGIONAL
FIGURE 151. KEY BUYING CRITERIA OF SHORT ACTING INSULIN MARKET
FIGURE 152. RESEARCH PROCESS OF MRFR
FIGURE 153. DRO ANALYSIS OF SHORT ACTING INSULIN MARKET
FIGURE 154. DRIVERS IMPACT ANALYSIS: SHORT ACTING INSULIN MARKET
FIGURE 155. RESTRAINTS IMPACT ANALYSIS: SHORT ACTING INSULIN MARKET
FIGURE 156. SUPPLY / VALUE CHAIN: SHORT ACTING INSULIN MARKET
FIGURE 157. SHORT ACTING INSULIN MARKET, BY INSULIN FORMULATION, 2024 (% SHARE)
FIGURE 158. SHORT ACTING INSULIN MARKET, BY INSULIN FORMULATION, 2019 TO 2032 (USD Billions)
FIGURE 159. SHORT ACTING INSULIN MARKET, BY DOSAGE FORM, 2024 (% SHARE)
FIGURE 160. SHORT ACTING INSULIN MARKET, BY DOSAGE FORM, 2019 TO 2032 (USD Billions)
FIGURE 161. SHORT ACTING INSULIN MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 162. SHORT ACTING INSULIN MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 163. SHORT ACTING INSULIN MARKET, BY PATIENT TYPE, 2024 (% SHARE)
FIGURE 164. SHORT ACTING INSULIN MARKET, BY PATIENT TYPE, 2019 TO 2032 (USD Billions)
FIGURE 165. SHORT ACTING INSULIN MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
FIGURE 166. SHORT ACTING INSULIN MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2032 (USD Billions)
FIGURE 167. SHORT ACTING INSULIN MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 168. SHORT ACTING INSULIN MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 169. BENCHMARKING OF MAJOR COMPETITORS
